Como parte de su compromiso con el sector biotecnológico, la Xunta de Galicia, a través de la Axencia Galega de Innovación GAIN y canalizado a través de BIOGA, está trabajando ya en el diseño y desarrollo de la Estrategia de Consolidación de la Biotecnología para el período 2021-2025.Será un proceso abierto a la participación activa de todo el ecosistema biotecnológico de la región que, partiendo de los resultados de la Estrategia de Impulso, permita identificar las áreas de actuación y las acciones prioritarias para el siguiente período, con el objetivo de afianzar el camino comenzado hace ya cuatro años para situar al sector en el lugar que merece y Galicia necesita.

Nos es grato anunciar la primera edición del seminario IP Perspectives Galicia, que ABG Intellectual Property y la Universidade de Santiago de Compostela organizan conjuntamente. El evento tendrá lugar el jueves 23 de abril de 2020 en el Edificio CIMUS de Santiago de Compostela, de 9h a 17h aproximadamente. El seminario contará con ponencias de reconocidos profesionales de la Propiedad Industrial así como representantes de la universidad y la industria, y tratará, entre otros, de los siguientes temas de actualidad:  ·         La gestión de la PI en el sector farmacéutico. ·         La protección de invenciones de software. ·         Los aspectos legales claves en la preparación y presentación de solicitudes de patente. ·         Transferencia Tecnológica en la USC. ·         Nanogap: un caso de éxito en el terreno de la nanotecnología.

The Health Cluster Portugal (HCP) is launching and promoting a Smart Health Network, as one of its Thematic Strategic Networks. This network aims to integrate organizations with relevant activity in the domains of medical technologies and digital health in order to promote activities and initiatives leading to the reinforcement of this segment of the national health sector and to the advancement of international competitiveness.This HCP initiative will be presented in detail during the HCP Meetings with Health Innovation, taking place on April 8th at the University of Coimbra. For more information on this network please email us to info@healthportugal.com.

Sesión informativa sobre el programa CaixaImpulse para la valorización de resultados de investigación de ciencias de la vida.

Biotalleres Smart Pitch - Actividades de formación específica con expertos de relevancia para el sector biotecnológico gallego. El objetivo de los Biotalleres Bioga es fomentar las habilidades y competencias empresariales de los participantes.El pitch, o la presentación resumida de la compañía o del proyecto, es el momento clave a la hora de conseguir el interés de los potenciales inversores y otros colaboradores. En este taller, se abordarán las recomendaciones más prácticas y tendremos oportunidad de ensayar los conceptos en "entorno seguro" para que tu próximo pitch sea un éxito.Ponente: María Seoane es Interim CEO de una spin off de la USC, emprendedora y cofundadora de Clínica Dialibre, con experiencia dilatada en el desarrollo de negocio de soluciones innovadoras en el ámbito médico y tenológico, es una entudiasta de la puesta en el mercado de ideas que reporten una clara mejora en la sociedad.

ingenyus* is a digital marketing & innovation consultancy agency, specialized in provide services to R&D institutions and innovative/disruptive companies. We provide the whole chain of services in marketing: since the development of the strategy to the deployment of every single action identify in the strategy. That is possible thanks to our specialized team. We count with - IT developers to develop custom made applications - Graphic designers, to think, create and execute disruptive campaigns that will allow you to impact your audience - Content managers, to help you out to build strong and coherent content, aligned with your communication strategy. - Scientific consultants, to understand your language, and therefore your business model and/or activity, in order to communicate it properly. Do not hestitate to visit our homepage to get more info: https://www.ingenyus.es/

The Health Cluster Portugal (HCP) is a private non-profit association, founded in 2008, that currently brings together more than 180 members, including R&D institutions, universities, hospitals, organizations from civil society, and companies in the areas of pharmaceuticals, biotechnology, medical technologies and services. Together, HCP and its members develop innovative projects in areas such as translational and clinical research, active and healthy ageing, health tourism, and eHealth, with the purpose of turning knowledge into new solutions that contribute to the improvement of human health and wellbeing. And also together, work to make Portugal the right place to invest and build partnerships in Health.To learn more about HCP, its members, and the Portuguese Health sector, please visit:- HCP's website (www.healthportugal.com);- HCP Membership Directory (www.healthportugal-directory.com);- SciPort | Health in Portugal: Science and Technology Resources Database (www.scienceportugal.com).- Presentation "Portugal: the right place to invest and build partnerships in Health"​ (https://www.slideshare.net/LusSoares12/portugal-the-right-place-to-invest-and-build-partnerships-in-health-august-2018).

Founded in 1990, TecMinho is a private non-profit association, having had as sponsors the University of Minho and the Association of Municipalities of Vale do Ave. Its basic mission is to be an interface of the University of Minho, promoting its connection to society, especially in the areas of science and technology, contributing to regional development by improving the competitiveness of organizations and increase the skills of individuals. Our quest for innovation and technological development takes place through 3 main lines of action: Continuing Training, Technology Transfer and University Entrepreneurship.  TecMinho's Intervention Strategy: - Promotion of innovation and development of new technologies / products / processes and their transfer to businesses; - Promotion of Continuous Training activities (including e-learning), as well as organizational development and transnational mobility of human resources; - Support to the creation of enterprises, with emphasis on academic spin-offs; - Kick-start of projects of research / development, as well as guidance in its implementation.

A Janssen é uma companhia farmacêutica, líder mundial em Investigação, que se dedica há mais de 60 anos ao desenvolvimento de medicamentos inovadores, com o objetivo de melhorar a qualidade e aumentar a esperança de vida de milhões de doentes em todo o mundo. Em Portugal, a Janssen conta com uma equipa de cerca de 100 colaboradores que contribuem para melhorar a saúde dos doentes e criar valor económico para o País. A Janssen integra um grupo mundial de companhias farmacêuticas: Faz parte do grupo Johnson & Johnson, com sede em New Brunswick, EUA; 35.000 colaboradores nos 5 continentes; Investiu cerca de €7 mil milhões em Investigação e Desenvolvimento em 2014; 5ª Maior Farmacêutica a nível global. A Janssen na Europa, Médio Oriente & África (EMEA) tem... Atividade em mais de 100 países; Escritórios em mais de 30 países; Mais de 14.000 colaboradores; Investimento em investigação e desenvolvimento é superior a €1,5 mil milhões, anualmente. Temos 8 centros de Investigação e Desenvolvimento na zona EMEA: Beerse, na Belgica; High Wycombe, no Reino Unido; Leiden (Janssen Biologics & Crucell), na Holanda; Val-de-Reuil, em França; Schaffhausen e Bern (Crucell), na Suíça; Toledo, em Espanha. Na região EMEA, temos 10 locais de produção, que produzem medicamentos para distribuição a nível global: Beerse, Geel e Olen, na Bélgica; Cork, na Irlanda; Latina, em Itália; Leiden, na Holanda; Madrid, (Crucell) em Espanha; Schaffhausen e Bern (Crucell), na Suíça; Solna (Crucell), na Suécia.